Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024
Heron Therapeutics (Nasdaq: HRTX), a commercial-stage biotechnology company, has announced it will host a conference call and live webcast on Tuesday, August 6, 2024, at 4:30 p.m. ET to report its second quarter 2024 financial results and discuss recent business highlights. Investors and interested parties can access the call by dialing (646) 307-1963 in the U.S. or (800) 715-9871 internationally, using the passcode 1737564. A webcast will also be available under the Investor Relations section of Heron's website at www.herontx.com. An archive of the teleconference and webcast will be accessible on the company's website for 60 days following the call.
Heron Therapeutics (Nasdaq: HRTX), una società di biotecnologia in fase commerciale, ha annunciato che il martedì 6 agosto 2024, alle 16:30 ET terrà una conferenza telefonica e un webcast in diretta per riportare i suoi risultati finanziari del secondo trimestre 2024 e discutere i recenti punti salienti dell'azienda. Gli investitori e le parti interessate possono accedere alla chiamata componendo (646) 307-1963 negli Stati Uniti o (800) 715-9871 a livello internazionale, utilizzando il passcode 1737564. Un webcast sarà disponibile anche nella sezione Relazioni con gli Investitori del sito web di Heron all'indirizzo www.herontx.com. Un archivio della teleconferenza e del webcast sarà accessibile sul sito dell'azienda per 60 giorni dopo la chiamata.
Heron Therapeutics (Nasdaq: HRTX), una empresa de biotecnología en etapa comercial, ha anunciado que llevará a cabo una llamada de conferencia y una transmisión en vivo el martes 6 de agosto de 2024, a las 4:30 p.m. ET para informar sobre sus resultados financieros del segundo trimestre de 2024 y discutir los aspectos destacados recientes del negocio. Los inversores y partes interesadas pueden acceder a la llamada marcando (646) 307-1963 en EE.UU. o (800) 715-9871 internacionalmente, utilizando el código de acceso 1737564. También estará disponible un webcast en la sección de Relaciones con Inversores del sitio web de Heron en www.herontx.com. Un archivo de la teleconferencia y del webcast estará accesible en el sitio web de la empresa durante 60 días después de la llamada.
헤론 테라퓨틱스 (Nasdaq: HRTX)는 상장 단계의 생명공학 회사로, 2024년 8월 6일 화요일 오후 4시 30분 ET에 컨퍼런스 콜과 라이브 웹캐스트를 진행한다고 발표했습니다. 이번 회의에서는 2024년 2분기 재무 결과를 보고하고 최근 사업 하이라이트에 대해 논의할 예정입니다. 투자자 및 관심 있는 분들은 미국에서 (646) 307-1963로 국제적으로는 (800) 715-9871로 전화하여 비밀번호 1737564를 사용하여 콜에 접속할 수 있습니다. 또한 헤론 웹사이트의 투자자 관계 섹션에서 웹캐스트를 확인할 수 있습니다. 통화 및 웹캐스트의 아카이브는 콜 후 60일 동안 회사 웹사이트에서 접근할 수 있습니다.
Heron Therapeutics (Nasdaq: HRTX), une entreprise de biotechnologie en phase commerciale, a annoncé qu'elle tiendra une conférence téléphonique et un webinaire en direct le mardi 6 août 2024 à 16h30 ET pour présenter ses résultats financiers du deuxième trimestre 2024 et discuter des récents points forts de l'entreprise. Les investisseurs et les parties intéressées peuvent accéder à l'appel en composant le (646) 307-1963 aux États-Unis ou le (800) 715-9871 à l'international, en utilisant le code d'accès 1737564. Un webinaire sera également disponible dans la section Relations avec les investisseurs du site Web de Heron à l'adresse www.herontx.com. Un enregistrement de la téléconférence et du webinaire sera accessible sur le site de l'entreprise pendant 60 jours après l'appel.
Heron Therapeutics (Nasdaq: HRTX), ein biotechnologisches Unternehmen in der kommerziellen Phase, hat angekündigt, dass es am Dienstag, den 6. August 2024, um 16:30 Uhr ET eine Telefonkonferenz und einen Live-Webcast abhalten wird, um seine finanziellen Ergebnisse für das zweite Quartal 2024 bekannt zu geben und über aktuelle Geschäftshighlights zu diskutieren. Investoren und Interessierte können an dem Anruf teilnehmen, indem sie in den USA (646) 307-1963 oder international (800) 715-9871 wählen und den Zugangscode 1737564 verwenden. Ein Webcast wird auch im Bereich Investor Relations auf der Website von Heron unter www.herontx.com verfügbar sein. Ein Archiv der Telefonkonferenz und des Webcasts wird 60 Tage nach dem Anruf auf der Website des Unternehmens zugänglich sein.
- None.
- None.
The conference call can be accessed by dialing (646) 307-1963 in the U.S. or (800) 715-9871 internationally. Please provide the operator with the passcode 1737564 to join the conference call. The conference call will also be available via webcast under the Investor Relations section of Heron's website at www.herontx.com. An archive of the teleconference and webcast will also be made available on Heron's website for 60 days following the call.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-second-quarter-2024-financial-results-on-tuesday-august-6-2024-302210141.html
SOURCE Heron Therapeutics, Inc.
FAQ
When will Heron Therapeutics (HRTX) report its Q2 2024 financial results?
How can investors access Heron Therapeutics' (HRTX) Q2 2024 earnings call?
Where can I find the webcast for Heron Therapeutics' (HRTX) Q2 2024 earnings call?
How long will the archive of Heron Therapeutics' (HRTX) Q2 2024 earnings call be available?
